News & Events

Hillgene has recently been officially recognized as a “Specialized and Innovative” enterprise, a national designation granted by the Chinese government to companies that demonstrate outstanding capa...

Meribank Biotech has recently announced a new collaboration focused on upgrading manufacturing capabilities for NK cell therapies, including process optimization and the integration of AI-driven quali...

The recent collaboration between MiNK Therapeutics and C-Further to advance a PRAME-targeted iNKT cell therapy for pediatric cancers reflects more than a single pipeline update. As noted in recent ind...

Iovance Biotherapeutics announced new clinical results for its tumor-infiltrating lymphocyte (TIL) therapy Lifileucel in patients with soft tissue sarcoma, highlighting the potential expansion of TIL ...

As spring ushers in a new beginning, everything is renewed with vitality. On March 6, 2026, Hillgene successfully held its Spring Gala themed “Upgrading Capabilities · Expanding Horizons · Shaping ...

March 2026 — Global Biotech NewsLentiviral vector technology continues to play a central role in the evolution of CAR-T cell therapies, as researchers advance strategies aimed at delivering chimeric ...

On February 19, 2026, Japan's Ministry of Health, Labour and Welfare (MHLW) granted conditional and time-limited approval to the world's first two induced pluripotent stem cell (iPSC)–based r...

February 2026 — Global Biotech NewsShanghai, China / Global — CARsgen Therapeutics Holdings Ltd., a clinical-stage biotechnology company focused on innovative chimeric antigen receptor T-cell (CAR-T...

February 2026 — Industry NewsThe global cell and gene therapy (CGT) sector continues to expand, with recent industry data highlighting a combination of strong product revenues, increasing regulatory ...

February 2026 — Global Biotech NewsSan Francisco, CA / USA — The U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND) application for SRN-101, an AAV-based immuno-ge...

February 2, 2026 — Global Biotech NewsSilver Spring, MD, USA — Senior officials at the U.S. Food and Drug Administration (FDA) have urged biotechnology companies to implement long-term monitoring of...

January 2026Sarepta Therapeutics announced new three-year follow-up data showing that its Duchenne muscular dystrophy (DMD) gene therapy Elevidys (delandistrogene moxeparvovec) continued to demonstrat...